Eli Lilly CEO: It's a great time for science in pharma sector 3 Hours Ago At the J.P. Morgan Health Care Conference, Eli Lilly CEO David Ricks speaks to CNBC's Meg Tirrell about the state of health care this year, drug pricing and the impact of tax reform on the pharmaceutical industry.